<!DOCTYPE html>
<!-- Generated by pkgdown: do not edit by hand --><html lang="en"><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><meta charset="utf-8"><meta http-equiv="X-UA-Compatible" content="IE=edge"><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no"><meta name="description" content="This dataset is a reduced version of the dataset colon from the package
survival (Therneau, T.M. et al., 2022). Each observation is a transition from
recurrence of colon cancer to death or censoring. The time scales are time
from randomization to recurrence, time from randomization to death or
censoring and time from recurrence. The original dataset does not present any
left truncated observation, since all the individuals are observed in the
state 'recurrence' right from entry in the state. To be able to illustrate
how to include left truncated times in the model, artificial left truncated
entry in the 'recurrence' state are introduced for 40 individuals.
Additionally, 7 individuals with exit from the risk set equal to entry in the
recurrence state (0 exposure time) were dropped from the sample."><title>Data from the chemotherapy for stace B/C colon cancer study — reccolon2ts • TwoTimeScales</title><script src="../deps/jquery-3.6.0/jquery-3.6.0.min.js"></script><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no"><link href="../deps/bootstrap-5.2.2/bootstrap.min.css" rel="stylesheet"><script src="../deps/bootstrap-5.2.2/bootstrap.bundle.min.js"></script><!-- Font Awesome icons --><link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.12.1/css/all.min.css" integrity="sha256-mmgLkCYLUQbXn0B1SRqzHar6dCnv9oZFPEC1g1cwlkk=" crossorigin="anonymous"><link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.12.1/css/v4-shims.min.css" integrity="sha256-wZjR52fzng1pJHwx4aV2AO3yyTOXrcDW7jBpJtTwVxw=" crossorigin="anonymous"><!-- bootstrap-toc --><script src="https://cdn.jsdelivr.net/gh/afeld/bootstrap-toc@v1.0.1/dist/bootstrap-toc.min.js" integrity="sha256-4veVQbu7//Lk5TSmc7YV48MxtMy98e26cf5MrgZYnwo=" crossorigin="anonymous"></script><!-- headroom.js --><script src="https://cdnjs.cloudflare.com/ajax/libs/headroom/0.11.0/headroom.min.js" integrity="sha256-AsUX4SJE1+yuDu5+mAVzJbuYNPHj/WroHuZ8Ir/CkE0=" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/headroom/0.11.0/jQuery.headroom.min.js" integrity="sha256-ZX/yNShbjqsohH1k95liqY9Gd8uOiE1S4vZc+9KQ1K4=" crossorigin="anonymous"></script><!-- clipboard.js --><script src="https://cdnjs.cloudflare.com/ajax/libs/clipboard.js/2.0.11/clipboard.min.js" integrity="sha512-7O5pXpc0oCRrxk8RUfDYFgn0nO1t+jLuIOQdOMRp4APB7uZ4vSjspzp5y6YDtDs4VzUSTbWzBFZ/LKJhnyFOKw==" crossorigin="anonymous" referrerpolicy="no-referrer"></script><!-- search --><script src="https://cdnjs.cloudflare.com/ajax/libs/fuse.js/6.4.6/fuse.js" integrity="sha512-zv6Ywkjyktsohkbp9bb45V6tEMoWhzFzXis+LrMehmJZZSys19Yxf1dopHx7WzIKxr5tK2dVcYmaCk2uqdjF4A==" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/autocomplete.js/0.38.0/autocomplete.jquery.min.js" integrity="sha512-GU9ayf+66Xx2TmpxqJpliWbT5PiGYxpaG8rfnBEk1LL8l1KGkRShhngwdXK1UgqhAzWpZHSiYPc09/NwDQIGyg==" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/mark.js/8.11.1/mark.min.js" integrity="sha512-5CYOlHXGh6QpOFA/TeTylKLWfB3ftPsde7AnmhuitiTX4K5SqCLBeKro6sPS8ilsz1Q4NRx3v8Ko2IBiszzdww==" crossorigin="anonymous"></script><!-- pkgdown --><script src="../pkgdown.js"></script><meta property="og:title" content="Data from the chemotherapy for stace B/C colon cancer study — reccolon2ts"><meta property="og:description" content="This dataset is a reduced version of the dataset colon from the package
survival (Therneau, T.M. et al., 2022). Each observation is a transition from
recurrence of colon cancer to death or censoring. The time scales are time
from randomization to recurrence, time from randomization to death or
censoring and time from recurrence. The original dataset does not present any
left truncated observation, since all the individuals are observed in the
state 'recurrence' right from entry in the state. To be able to illustrate
how to include left truncated times in the model, artificial left truncated
entry in the 'recurrence' state are introduced for 40 individuals.
Additionally, 7 individuals with exit from the risk set equal to entry in the
recurrence state (0 exposure time) were dropped from the sample."><!-- mathjax --><script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.5/MathJax.js" integrity="sha256-nvJJv9wWKEm88qvoQl9ekL2J+k/RWIsaSScxxlsrv8k=" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.5/config/TeX-AMS-MML_HTMLorMML.js" integrity="sha256-84DKXVJXs0/F8OTMzX4UR909+jtl4G7SPypPavF+GfA=" crossorigin="anonymous"></script><!--[if lt IE 9]>
<script src="https://oss.maxcdn.com/html5shiv/3.7.3/html5shiv.min.js"></script>
<script src="https://oss.maxcdn.com/respond/1.4.2/respond.min.js"></script>
<![endif]--></head><body>
    <a href="#main" class="visually-hidden-focusable">Skip to contents</a>
    

    <nav class="navbar fixed-top navbar-dark navbar-expand-lg bg-primary" data-bs-theme="dark"><div class="container">
    
    <a class="navbar-brand me-2" href="../index.html">TwoTimeScales</a>

    <small class="nav-text text-muted me-auto" data-bs-toggle="tooltip" data-bs-placement="bottom" title="">0.3.0</small>

    
    <button class="navbar-toggler" type="button" data-bs-toggle="collapse" data-bs-target="#navbar" aria-controls="navbar" aria-expanded="false" aria-label="Toggle navigation">
      <span class="navbar-toggler-icon"></span>
    </button>

    <div id="navbar" class="collapse navbar-collapse ms-3">
      <ul class="navbar-nav me-auto"><li class="nav-item">
  <a class="nav-link" href="../index.html">
    <span class="fa fa-home"></span>
     
  </a>
</li>
<li class="nav-item">
  <a class="nav-link" href="../articles/index.html">Vignettes</a>
</li>
      </ul><form class="form-inline my-2 my-lg-0" role="search">
        <input type="search" class="form-control me-sm-2" aria-label="Toggle navigation" name="search-input" data-search-index="../search.json" id="search-input" placeholder="Search for" autocomplete="off"></form>

      <ul class="navbar-nav"><li class="active nav-item">
  <a class="nav-link" href="../reference/index.html">
    <span class="fa fa-file-code-o"></span>
     
    functions
  </a>
</li>
<li class="nav-item">
  <a class="external-link nav-link" href="https://github.com/AngelaCar/TwoTimeScales">
    <span class="fa fa-github fa-lg fab"></span>
     
    github
  </a>
</li>
      </ul></div>

    
  </div>
</nav><div class="container template-reference-topic">
<div class="row">
  <main id="main" class="col-md-9"><div class="page-header">
      <img src="" class="logo" alt=""><h1>Data from the chemotherapy for stace B/C colon cancer study</h1>
      <small class="dont-index">Source: <a href="https://github.com/AngelaCar/TwoTimeScales/blob/HEAD/R/data.R" class="external-link"><code>R/data.R</code></a></small>
      <div class="d-none name"><code>reccolon2ts.Rd</code></div>
    </div>

    <div class="ref-description section level2">
    <p>This dataset is a reduced version of the dataset colon from the package
survival (Therneau, T.M. et al., 2022). Each observation is a transition from
recurrence of colon cancer to death or censoring. The time scales are time
from randomization to recurrence, time from randomization to death or
censoring and time from recurrence. The original dataset does not present any
left truncated observation, since all the individuals are observed in the
state 'recurrence' right from entry in the state. To be able to illustrate
how to include left truncated times in the model, artificial left truncated
entry in the 'recurrence' state are introduced for 40 individuals.
Additionally, 7 individuals with exit from the risk set equal to entry in the
recurrence state (0 exposure time) were dropped from the sample.</p>
    </div>

    <div class="section level2">
    <h2 id="ref-usage">Usage<a class="anchor" aria-label="anchor" href="#ref-usage"></a></h2>
    <div class="sourceCode"><pre class="sourceCode r"><code><span><span class="fu"><a href="https://rdrr.io/r/utils/data.html" class="external-link">data</a></span><span class="op">(</span><span class="va">reccolon2ts</span><span class="op">)</span></span></code></pre></div>
    </div>

    <div class="section level2">
    <h2 id="format">Format<a class="anchor" aria-label="anchor" href="#format"></a></h2>
    
<div class="section">
<h3 id="reccolon-ts-a-data-table-with-rows-and-columns-">reccolon2ts A data.table with 461 rows and 25 columns:<a class="anchor" aria-label="anchor" href="#reccolon-ts-a-data-table-with-rows-and-columns-"></a></h3>


<dl><dt>id</dt>
<dd><p>patient's id</p></dd>

<dt>study</dt>
<dd><p>1 for all patients</p></dd>

<dt>rx</dt>
<dd><p>Treatment - Obs(ervation), Lev(amisole), Lev(amisole)+5-FU</p></dd>

<dt>sex</dt>
<dd><p>1=male, 0=female</p></dd>

<dt>age</dt>
<dd><p>Age at transplant in years</p></dd>

<dt>obstruct</dt>
<dd><p>obstruction of colon by tumor: 1=yes</p></dd>

<dt>perfor</dt>
<dd><p>perforation of colon: 1=yes</p></dd>

<dt>adhere</dt>
<dd><p>adherence to nearby organs: 1=yes</p></dd>

<dt>nodes</dt>
<dd><p>number of lymph nodes with detectable cancer</p></dd>

<dt>status</dt>
<dd><p>censoring status: 0=censoring, 1=event</p></dd>

<dt>differ</dt>
<dd><p>differentiation of tumour: 1=well, 2=moderate, 3=poor</p></dd>

<dt>extent</dt>
<dd><p>extent of local spread: 1=submucosa, 2=muscle, 3=serosa,
4=contigous structures</p></dd>

<dt>surg</dt>
<dd><p>time from surgery to registration: 0=short, 1=long</p></dd>

<dt>node4</dt>
<dd><p>more than 4 positive lymph nodes</p></dd>

<dt>etype</dt>
<dd><p>2 for all patients (2=death)</p></dd>

<dt>timedc</dt>
<dd><p>time in days from randomization to death or censoring</p></dd>

<dt>timer</dt>
<dd><p>time in days from randomization to recurrence</p></dd>

<dt>timesr</dt>
<dd><p>time in days from recurrence to death or censoring</p></dd>

<dt>entrys</dt>
<dd><p>artificial entry time on the time since
recurrence scale. For most of the individual this is 0 (no left
truncation). For 40 individuals a random number between 1 and the exit time
on the time since recurrence scale (timesr) is simulated.</p></dd>

<dt>entryt</dt>
<dd><p>time in days from randomization to observation in the
recurrence state. If the individual is observed from entry in the
recurrence state this is equal to the time at recurrence. If the entry in
the recurrence state is not observed from the beginning, left truncation is
observed. This is not present in the original data, but has been here
introduced artificially for 40 individuals. This is done by first
increasing the time at recurrence by a random number between 1 and the exit
time on the time since recurrence scale. Then, the time at recurrence is
added to the artificial entry time.</p></dd>

<dt>timedc_y</dt>
<dd><p>time in years from randomization to death or censoring</p></dd>

<dt>timer_y</dt>
<dd><p>time in years from randomization to recurrence</p></dd>

<dt>entrys_y</dt>
<dd><p>left truncated entry in the recurrence state measured in
years since recurrence</p></dd>

<dt>entryt_y</dt>
<dd><p>left truncated entry in the recurrence state measured in
years since randomization</p></dd>

<dt>timesr_y</dt>
<dd><p>time in years from recurrence to death or
censoring</p></dd>
 
</dl></div>

    </div>
    <div class="section level2">
    <h2 id="source">Source<a class="anchor" aria-label="anchor" href="#source"></a></h2>
    <p>Therneau, T. (2023). A Package for Survival Analysis in R. R package
version 3.5-3, <a href="https://CRAN.R-project.org/package=survival" class="external-link">https://CRAN.R-project.org/package=survival</a></p>
    </div>
    <div class="section level2">
    <h2 id="references">References<a class="anchor" aria-label="anchor" href="#references"></a></h2>
    <p>Moertel, C.G, et al. (1995). Fluorouracil plus Levamisole as
Effective Adjuvant Theraphy after Resection of Stage III Colon Carcinoma: A
Final Report. Annals of Internal Medicine, 122:321-326</p>
<p>Moerel, C.G., et al. (1990). Levamisole and Fluorouracil for Adjvant
Theraphy of Resected Colon Carcinoma. The New England Journal of Medicine,
322:352-8</p>
    </div>

    <div class="section level2">
    <h2 id="ref-examples">Examples<a class="anchor" aria-label="anchor" href="#ref-examples"></a></h2>
    <div class="sourceCode"><pre class="sourceCode r"><code><span class="r-in"><span><span class="fu"><a href="https://rdrr.io/r/utils/data.html" class="external-link">data</a></span><span class="op">(</span><span class="va">reccolon2ts</span><span class="op">)</span></span></span>
<span class="r-in"><span></span></span>
</code></pre></div>
    </div>
  </main><aside class="col-md-3"><nav id="toc"><h2>On this page</h2>
    </nav></aside></div>


    <footer><div class="pkgdown-footer-left">
  <p>Developed by Angela Carollo, Paul H.C. Eilers, Jutta Gampe.</p>
</div>

<div class="pkgdown-footer-right">
  <p>Site built with <a href="https://pkgdown.r-lib.org/" class="external-link">pkgdown</a> 2.0.9.</p>
</div>

    </footer></div>

  

  

  </body></html>

